# China%20Healthcare
Latest news and articles about China%20Healthcare
Total: 15 articles found
Sinopharm’s Shopping Spree: Can M&A Cure the Giant’s Growing Pains?
Sinopharm Group is attempting to offset a stagnation in its core distribution business through a 10-billion-RMB acquisition spree in the diagnostics and blood-product sectors. However, the group faces significant hurdles, including high debt, internal competition among its 1,700 subsidiaries, and the ongoing pressure of China's centralized drug procurement policies.
China’s Healthcare Frontier: Breaking the Provincial Barriers of Medical Insurance
China has introduced a 'Personal Insurance Wallet' system that allows employees to share their medical insurance funds with family members across provincial lines. This reform aims to support the country's mobile workforce and aging population by removing regional administrative barriers to healthcare spending.
Closing the Treatment Gap: Weiguang Biological Advances Hemophilia B Candidate in China
Weiguang Biological has received regulatory approval to begin clinical trials for Human Coagulation Factor IX, targeting Hemophilia B. This development marks a significant step in China's domestic rare disease treatment capabilities, though the company warns of the long-term risks inherent in drug development.
Monetizing the Pulse: China’s Hospital Data Gold Rush and the Erosion of Patient Privacy
China's public hospitals are increasingly selling patient datasets to pharmaceutical and AI companies under a state-led mandate to monetize 'data elements.' While this fuels medical innovation, it raises significant legal and ethical questions regarding patient privacy and the lack of specific informed consent for commercial data use.
Cloudy Vision: China’s ‘Eye King’ Faces $72 Million Tax Bill on the Eve of Hong Kong IPO
Aier Eye Hospital, China's largest private ophthalmology chain, has been hit with a 524 million yuan tax penalty just as it prepares for a Hong Kong IPO. The company is grappling with its first profit decline in 17 years and mounting scrutiny over its aggressive acquisition strategy and controversial 'charity-based' business model.
Zhenghai Bio-tech Advances China’s Regenerative Frontier with Stem Cell Milestone
Zhenghai Bio-tech has reached the product validation phase for its human umbilical cord mesenchymal stem cell project. This milestone signifies a major step in the company's shift toward advanced cellular therapy and regenerative medicine.
Precision Under Pressure: The Strategic Evolution of Nursing in China’s Military Hospitals
Senior Nurse Cheng Lingyan of the PLA General Hospital exemplifies a shift toward high-tech, innovation-driven military healthcare in China. Her work in developing patented medical devices and leading a 'Nursing Iron Army' signals the PLA's commitment to clinical self-reliance and professionalized military medical services.
The 30,000-Yuan Red Line: China’s Healthcare Sector Reels Under Strict New Anti-Bribery Rules
China has introduced a strict new judicial interpretation lowering the criminal prosecution threshold for healthcare bribery to 30,000 RMB, triggering widespread panic among doctors and pharmaceutical firms. The move targets both public and private sectors, holding companies liable for employee misconduct and signaling an end to the era of relationship-based medical sales.
Regulatory Renaissance: How New Policy Orders are Unlocking China’s Stem Cell Ambitions
China is implementing a landmark regulatory overhaul to streamline the transition of stem cell research from hospital labs to clinical practice. Centered in Shanghai's Zhangjiang hub, this new policy framework aims to leverage real-world clinical data to establish global leadership in regenerative medicine while enforcing strict ethical and safety standards.
Power Asymmetry and Private Healthcare: Aier Eye Hospital Scandal Sparks Outcry Over Workplace Harassment in China
The director of Hangzhou Aier Eye Hospital has been suspended following allegations of sexually harassing a pharmaceutical sales manager. The case has ignited a national conversation regarding workplace power dynamics, professional retaliation, and the legal challenges victims face in prosecuting harassment in China.
Healing the Frontline: Why a Military Doctor's Empathy is Resonating Across China
The viral story of military doctor Dai Jigang's empathetic care highlights the systemic pressures of China's healthcare system and the unique role of military medicine in maintaining public trust. By offering both in-person and digital consultations, Dai addresses the massive rural-urban divide in medical access.
Beyond the Scalpel: A Military Doctor and the Human Face of China’s Healthcare Strain
Military doctor Dai Jigang has gained national attention for his empathetic treatment of patients and his commitment to offering free online consultations. His actions shed light on the massive disparities in China's healthcare system and the evolving role of PLA medical personnel in civil society.